QA: Tempest Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001544227_2023_Tempest_Therapeutics_Inc.pdf

Logs

warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001544227', 'EntityCommonStockSharesOutstanding': 10561700, 'Assets': 46089000, 'AssetsCurrent': 32950000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 27978000, 'LiabilitiesAndStockholdersEquity': 46089000, 'LiabilitiesCurrent': 7277000, 'LiabilitiesNoncurrent': 20701000, 'NetIncome': -35709000, 'PropertyPlantAndEquipmentNet': 1060000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 12079000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_NetIncome': -35709000, 'remainder_Revenues': 0, 'remainder_StockholdersEquity': 18111000, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001544227')"}

Edgar->Model Mapping